Search Results - "Perlmutter, J"

Refine Results
  1. 1

    Neurologist care in Parkinson disease: A utilization, outcomes, and survival study by WILLIS, A. W, SCHOOTMAN, M, EVANOFF, B. A, PERLMUTTER, J. S, RACETTE, B. A

    Published in Neurology (30-08-2011)
    “…To investigate the utilization of neurologist providers in the treatment of patients with Parkinson disease (PD) in the United States and determine whether…”
    Get full text
    Journal Article
  2. 2

    In vivo amyloid imaging in autopsy-confirmed Parkinson disease with dementia by BURACK, M. A, HARTLEIN, J, FLORES, H. P, TAYLOR-REINWALD, L, PERLMUTTER, J. S, CAIRNS, N. J

    Published in Neurology (05-01-2010)
    “…To investigate the specificity of in vivo amyloid imaging with [(11)C]-Pittsburgh Compound B (PIB) in Parkinson disease dementia (PDD). We performed detailed…”
    Get full text
    Journal Article
  3. 3

    Prevalence of parkinsonism and relationship to exposure in a large sample of Alabama welders by RACETTE, B. A, TABBAL, S. D, JENNINGS, D, GOOD, L, PERLMUTTER, J. S, EVANOFF, B

    Published in Neurology (25-01-2005)
    “…To estimate the prevalence of parkinsonism in welders in Alabama and to compare this prevalence with that in a general population sample. The authors screened…”
    Get full text
    Journal Article
  4. 4

    Severe acute neurotoxicity reflects absolute intra-carotid 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine dose in non-human primates by Norris, SA, White, HCB, Tanenbaum, A., Williams, EL, Cruchaga, C., Tian, L., Schmidt, RE, Perlmutter, JS

    Published in Journal of neuroscience methods (15-01-2022)
    “…•Absolute MPTP dose differed with acute recovery versus severe acute neurotoxicity.•Body weight and mean brain volume did not differ across outcome…”
    Get full text
    Journal Article
  5. 5

    Novel THAP1 sequence variants in primary dystonia by XIAO, J, ZHAO, Y, VAN GERPEN, J. A, SIMON, D. K, TARSY, D, HEDERA, P, TRUONG, D. D, FREI, K. P, DEV BATISH, S, BLITZER, A, PFEIFFER, R. F, GONG, S, BASTIAN, R. W, LEDOUX, M. S, PERLMUTTER, J. S, RACETTE, B. A, TABBAL, S. D, KARIMI, M, PANIELLO, R. C, WSZOLEK, Z. K, UITTI, R. J

    Published in Neurology (19-01-2010)
    “…THAP1 encodes a transcription factor (THAP1) that harbors an atypical zinc finger domain and regulates cell proliferation. An exon 2 insertion/deletion…”
    Get full text
    Journal Article
  6. 6

    Stimulation of STN impairs aspects of cognitive control in PD by HERSHEY, T, REVILLA, F. J, WERNLE, A, GIBSON, P. Schneider, DOWLING, J. L, PERLMUTTER, J. S

    Published in Neurology (13-04-2004)
    “…To test the hypothesis that subthalamic nucleus (STN) stimulation in Parkinson disease (PD) patients affects working memory and response inhibition…”
    Get full text
    Journal Article
  7. 7

    Practice Parameter:Diagnosis and prognosis of new onset Parkinson disease (an evidence-based review) : Report of the quality standards subcommittee of the american academy of neurology by SUCHOWERSKY, O, REICH, S, PERLMUTTER, J, ZESIEWICZ, T, GRONSETH, G, WEINER, W. J

    Published in Neurology (11-04-2006)
    “…To define key issues in the diagnosis of Parkinson disease (PD), to define features influencing progression, and to make evidence-based recommendations. Two…”
    Get full text
    Journal Article
  8. 8

    Dopamine pathway loss in nucleus accumbens and ventral tegmental area predicts apathetic behavior in MPTP-lesioned monkeys by Brown, C.A., Campbell, M.C., Karimi, M., Tabbal, S.D., Loftin, S.K., Tian, L.L., Moerlein, S.M., Perlmutter, J.S.

    Published in Experimental neurology (01-07-2012)
    “…Apathy, primarily defined as a lack of motivation, commonly occurs in people with Parkinson disease (PD). Although dysfunction of basal ganglia pathways may…”
    Get full text
    Journal Article
  9. 9
  10. 10

    Reduced uptake of [18 F]FDOPA PET in asymptomatic welders with occupational manganese exposure by CRISWELL, S. R, PERLMUTTER, J. S, VIDEEN, T. O, MOERLEIN, S. M, FLORES, H. P, BIRKE, A. M, RACETTE, B. A

    Published in Neurology (12-04-2011)
    “…Welding exposes workers to manganese (Mn) fumes, but it is unclear if this exposure damages dopaminergic neurons in the basal ganglia and predisposes…”
    Get full text
    Journal Article
  11. 11
  12. 12

    Practice Parameter:Neuroprotective strategies and alternative therapies for Parkinson disease (an evidence-based review) : Report of the quality standards subcommittee of the american academy of neurology by SUCHOWERSKY, O, GRONSETH, G, PERLMUTTER, J, REICH, S, ZESIEWICZ, T, WEINER, W. J

    Published in Neurology (11-04-2006)
    “…To define key issues in the management of Parkinson disease (PD) relating to neuroprotective strategies and alternative treatments, and to make evidence-based…”
    Get full text
    Journal Article
  13. 13

    Effects of deep brain stimulation of dorsal versus ventral subthalamic nucleus regions on gait and balance in Parkinson's disease by McNeely, M E, Hershey, T, Campbell, M C, Tabbal, S D, Karimi, M, Hartlein, J M, Lugar, H M, Revilla, F J, Perlmutter, J S, Earhart, G M

    “…ObjectiveDeep brain stimulation (DBS) of the subthalamic nucleus (STN) improves motor function, including gait and stability, in people with Parkinson's…”
    Get full text
    Journal Article
  14. 14

    Welding-related parkinsonism: Clinical features, treatment, and pathophysiology by RACETTE, B. A, MCGEE-MINNICH, L, MOERLEIN, S. M, MINK, J. W, VIDEEN, T. O, PERLMUTTER, J. S

    Published in Neurology (09-01-2001)
    “…To determine whether welding-related parkinsonism differs from idiopathic PD. Welding is considered a cause of parkinsonism, but little information is…”
    Get full text
    Journal Article
  15. 15

    Therapeutic plasma exchange and intravenous immunoglobulin for obsessive-compulsive disorder and tic disorders in childhood by Perlmutter, Susan J, Leitman, Susan F, Garvey, Marjorie A, Hamburger, Susan, Feldman, Elad, Leonard, Henrietta L, Swedo, Susan E

    Published in The Lancet (British edition) (02-10-1999)
    “…In children, exacerbations of tics and obsessive symptoms may occur after infection with group A β-haemolytic streptococci. If post-streptococcal autoimmunity…”
    Get full text
    Journal Article
  16. 16

    Regulation of dopamine D3 receptor in the striatal regions and substantia nigra in diffuse Lewy body disease by Sun, J, Cairns, N.J, Perlmutter, J.S, Mach, R.H, Xu, J

    Published in Neuroscience (17-09-2013)
    “…Highlights • Quantitative autoradiography of dopamine D1 , D2 , D3 receptors, VMAT2 and DAT. • Dopamine D2 and D3 receptor densities were measured using a…”
    Get full text
    Journal Article
  17. 17

    Subthalamic nucleus stimulation-induced regional blood flow responses correlate with improvement of motor signs in Parkinson disease by Karimi, M., Golchin, N., Tabbal, S. D., Hershey, T., Videen, T. O., Wu, J., Usche, J. W. M., Revilla, F. J., Hartlein, J. M., Wernle, A. R., Mink, J. W., Perlmutter, J. S.

    Published in Brain (London, England : 1878) (01-10-2008)
    “…Deep brain stimulation of the subthalamic nucleus (STN DBS) improves motor symptoms in idiopathic Parkinson's disease, yet the mechanism of action remains…”
    Get full text
    Journal Article
  18. 18
  19. 19

    Cerebral blood flow responses to dorsal and ventral STN DBS correlate with gait and balance responses in Parkinson's disease by Hill, K.K., Campbell, M.C., McNeely, M.E., Karimi, M., Ushe, M., Tabbal, S.D., Hershey, T., Flores, H.P., Hartlein, J.M., Lugar, H.M., Revilla, F.J., Videen, T.O., Earhart, G.M., Perlmutter, J.S.

    Published in Experimental neurology (01-03-2013)
    “…The effects of subthalamic nucleus (STN) deep brain stimulation (DBS) on gait and balance vary and the underlying mechanisms remain unclear. DBS location may…”
    Get full text
    Journal Article
  20. 20

    Pathologic correlates of supranuclear gaze palsy with parkinsonism by Martin, W.R.W, Hartlein, J, Racette, B.A, Cairns, N, Perlmutter, J.S

    Published in Parkinsonism & related disorders (01-05-2017)
    “…Abstract Introduction Supranuclear gaze palsy (SGP) is a classic clinical feature of progressive supranuclear palsy (PSP) but is not specific for this…”
    Get full text
    Journal Article